29th AnnualCardiovascular Interventions 2018

October 23-26, 2018Hilton La Jolla Torrey Pines

La Jolla, CA

Course Director:Paul S. Teirstein, MD, DNBPAS, FACC, FSCAI

Scripps Course Co-Directors:Matthew J. Price, MD, FACC, FSCAI

Richard A. Schatz, MD, FACCCurtiss T. Stinis, MD, FACC, FSCAI

COURSE OVERVIEW

Cardiologists are trained during their fellowship years in the latest techniques, technologies,standards of practice and guidelines for patient care. However, the practice of medicine changesrapidly and the discipline of interventional cardiology changes dramatically each year. Changesin interventional cardiology directly impact patient care and require constant updates tophysician knowledge and practices. Physicians rely on journal articles, interaction withcolleagues and lectures throughout the year to keep their knowledge up-to-date. The primarypurpose of the “29th Annual Cardiovascular Interventions” symposium is to provide thepracticing physician and cardiovascular care team with a concentrated exposure to newdevelopments in interventional cardiology that will positively influence patient outcomes.

The 2018 scientific program has been carefully designed by consulting recent key clinical trialdata, articles in peer-reviewed scientific journals, physician focus groups, past evaluations, andneeds assessments. By attending this program, participants will learn the latest advances anddebates in interventional cardiology. They will return to their practice environment armed withthe latest evidence-based, practical information to improve patient care and outcomes.

EDUCATIONAL OBJECTIVES

After attending this educational activity, participants should be able to:

Apply new technical approaches to specific lesion subsets such as bifurcation lesions, leftmain lesions, chronic total occlusions and saphenous vein graft disease

Integrate the latest guidelines and practice improvements into the management ofmyocardial function

Discuss new techniques under development for percutaneous cardiac valve repair andreplacement

Reduce common catheterization laboratory patient complications using new techniquesand technologies

Critique the latest evidence supporting new cardiac imaging modalities such as IVUS,OCT and FFR guided stent deployment

Prescribe the appropriate antithrombotic therapies based on the latest data and guidelines

TARGET AUDIENCE

This course is designed for interventional cardiologists, cardiac surgeons, vascular surgeons,internists, nurses, cath lab technicians, perfusionists, registered cardiovascular invasive specialists,radiologic techologists, and those with a special interest in interventional cardiology. No experiencein interventional cardiology is required, however a basic understanding of the field is recommended.

FACULTY DISCLOSURES

In accordance with the ACCME Standards for Commercial Support, course directors, planningcommittees, faculty and all others in control of the educational content of the CME activity mustdisclose all relevant financial relationships with any commercial interest that they or theirspouse/partner may have had within the past 12 months. If an individual refuses to disclose relevantfinancial relationships, they will be disqualified from being a part of the planning andimplementation of this CME activity. Employees of a commercial interest with business lines orproducts relating to the content of the CME activity will not participate in the planning orimplementation of the accredited portions of the symposium. Individual disclosures will be made toall participants at the conference location prior to the educational activity commencement and areavailable in the online syllabus.

ONLINE SYLLABUS

Slides presented during the accredited portions of the symposium (when approved by thespeaker), along with all meeting reference materials are available online athttp://www.cvinterventions.com/syllabus2018.html. Approved slides will be posted online asPDFs within 24 hours of presentation.

RADIATION SAFETY

This conference fulfills the Title 17 California Code requirement for 4 CE credits in radiationsafety for the clinical uses of fluoroscopy.

Radiation safety materials have been included in the online syllabus for your reference athttp://www.cvinterventions.com/syllabus2018.html.

CME ACCREDITATION & DESIGNATION

Physicians & Physician Assistants

Promedica International is accredited by the Accreditation Council for ContinuingMedical Education (ACCME) to provide continuing medical education for physicians.

Promedica International designates this live activity for a maximum of 23 AMA PRACategory 1 Credits ™. Physicians should claim only the credit commensurate with theextent of their participation in the activity.

Nurses

Provider approved by the California Board of Registered Nursing, Provider #8495 for 23 ContactHours.

Perfusionists

The American Board of Cardiovascular Perfusion (ABCP) has approved a total of 27.6 Category1 CEUs for perfusionists for Wednesday, October 24 (4.8), Thursday, October 25 (11.4), andFriday, October 26 (11.4).

Radiologic Technologists

The “Cardiovascular Interventions” symposium has been approved by the ASRT for Category Acontinuing education credit. Each session is accredited individually, detailed below.

Wednesday, Oct 24 – 1:30 – 3:30 PM Session (2.25 Category A Credits) Wednesday, Oct 24 – 4:00 – 6:00 PM Session (2.25 Category A Credits) Thursday, Oct 25 – 7:30 – 9:30 AM Session (2.25 Category A Credits) Thursday, Oct 25 – 10:00 AM – 12:00 PM Session (2.25 Category A Credits) Thursday, Oct 25 – 12:00 – 1:30 PM Session (1.75 Category A Credits) Thursday, Oct 25 – 1:30 – 3:30 PM Session (2.25 Category A Credits) Thursday, Oct 25 – 4:00 – 6:00 PM Session (2.25 Category A Credits) Friday, Oct 26 – 7:30 – 9:30 AM Session (2.25 Category A Credits) Friday, Oct 26 – 10:00 AM – 12:00 PM Session (2.25 Category A Credits) Friday, Oct 26 – 12:00 – 1:30 PM Session (1 Category A Credit) Friday, Oct 26 – 1:30 – 3:30 PM Session (2.25 Category A Credits) Friday, Oct 26 – 4:00 – 6:00 PM Session (2.25 Category A Credits)

Registered Cardiovascular Invasive Specialists (RCIS)

CCI does not approve CEUs directly however CCI will accept CEUs that have already beenapproved by accredited sponsors of the Accreditation Council for Continuing Medical Education(ACCME). RCIS attendees will claim the physician certificate option when completing theonline evaluation and can use that certificate to claim CEUs from CCI.

ABIM MOC POINTS

Successful completion of this CME activity, which includes participation inthe evaluation component, enables the participant to earn up to 23 MedicalKnowledge MOC points and Patient Safety MOC credit in the American

Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participantswill earn MOC points equivalent to the amount of CME credits claimed for the activity. It is theCME activity provider’s responsibility to submit participant completion information to ACCME forthe purpose of granting ABIM MOC credit.

Please keep in mind the following dates when claiming your MOC points:Physicians claiming MOC points for their participation in the symposium must complete theonline program evaluation by December 14, 2018 in order for the MOC points to count towardany MOC requirements that are due by the end of 2018.

Evaluations received after December 14, 2018 and before March 15, 2019 will continue to bereported to ABIM and any ABIM Board Certified physician who experienced a negative statuschange as a direct result of insufficient MOC points will have their status adjusted once therequired points have been earned.

If you need the MOC points to count for your 2018 record, please be sure tosubmit your evaluation by December 14, 2018. MOC points will not beavailable for this course after March 15, 2019.

CLAIMING YOUR CME/CE CERTIFICATE

1. Visit https://promedicacme.com/ and scroll down2. In the Past CME Symposia section, click “Take Evaluation” by the CI 2018 icon3. Complete the appropriate program evaluation4. Your CME certificate will be emailed to you within 2 weeks of submission

Please note the following:*Physicians will also be able to claim ABIM MOC points for 2018 via the online evaluation form throughDecember 14, 2018.

EDUCATIONAL GRANTS

This program is supported, in part, by educational grants from industry, inaccordance with the ACCME’s Standards for Commercial Support.

We gratefully acknowledge and thank the following contributors who have givengenerously to support this symposium.

Abbott

Abiomed, Inc.

AstraZeneca

BIOTRONIK, Inc.

Boston Scientific

Cardiovascular Systems, Inc.

Chiesi USA, Inc.

Edwards Lifesciences

Medtronic

Philips

EXHIBITS, PROMOTIONAL &SATELLITE SYMPOSIA ACKNOWLEDGEMENTS

Abbott

Abiomed, Inc.

ACIST Medical Systems, Inc.

Amgen

Asahi Intecc USA

AstraZeneca

BD(Formerly Bard Peripheral Vascular)

Boston Scientific

Cardiovascular Systems, Inc.

Chiesi USA, Inc.

Cook Medical

Cordis, a Cardinal Health Company

Edwards Lifesciences

GE Healthcare

Gilead

Gore & Associates

HeartFlow

Janssen Pharmaceuticals, Inc.

Medicure Pharma

Medtronic

National Board of Physicians and Surgeons (NBPAS)

Opsens Medical

Ostial Corporation

Philips

Preventice Solutions

Sanofi

Teleflex

Terumo Interventional Systems

COURSE DIRECTOR

Paul S. Teirstein, MD, DNBPAS, FACC, FSCAIChief of Cardiology

Director, Interventional CardiologyScripps Clinic

Director, Scripps Prebys Cardiovascular InstituteScripps HealthLa Jolla, CA

SCRIPPS COURSE CO-DIRECTORS

Matthew J. Price, MD, FACC, FSCAIDirector, Cardiac Catheterization Laboratory

Scripps ClinicAssistant Professor

Scripps Translational Science InstituteLa Jolla, CA

Richard A. Schatz, MD, FACCResearch Director, Cardiovascular Interventions

Director, Gene and Cell TherapyScripps ClinicLa Jolla, CA

Curtiss T. Stinis, MD, FACC, FSCAIDirector, Peripheral Interventions

Director, Interventional Cardiology Fellowship ProgramScripps ClinicLa Jolla, CA

SYMPOSIUM FACULTY

Ziad Ali, MD, DPhilAssistant Professor of Medicine

Director, Intravascular Imaging and PhysiologyDirector, Cardio-Renal Program

Columbia University Medical CenterNew York Presbyterian Hospital

Director, Angiographic Core LaboratoryCardiovascular Research Foundation

New York, NY

Daniel Burkhoff, MD, PhDDirector, Heart Failure, Hemodynamics and MCS Research

Cardiovascular Research FoundationNew York, NY

Jorge A. Gonzalez, MD, FACC, FSCMRDirector, Advanced Cardiovascular Imaging (CT/MRI)

Co-Director, Hypertrophic Cardiomyopathy ClinicDirector, Aortic Imaging Clinic

Scripps Clinic Division of Cardiovascular DiseasesScripps Clinic Division of Radiology

La Jolla, CA

J. Aaron Grantham, MD, FACC, FSCAIAssociate Professor of Medicine

Consulting CardiologistSaint Luke’s Mid America Heart Institute

Kansas City, Missouri

Cindy Grines, MD, FACC, FSCAIChair Interim - Cardiology Department

North Shore University HospitalAcademic Chair of Cardiology

Hofstra Northwell School of MedicineManhasset, NY

James Hermiller, MD, FACC, MSCAIDirector, Interventional Cardiology

Director, Interventional Cardiology FellowshipSt. Vincent Heart Center

Indianapolis, IN

Amir Kaki, MD, FACC, FSCAIMedical Director, Cardiac Cath Lab

DMC Heart HospitalDetroit, MI

Dean Kereiakes, MD, FACCMedical Director

The Christ Hospital Heart and Vascular CenterThe Carl and Edyth Lindner Center for Research and Education

The Christ HospitalCincinnati, OH

Morton Kern, MD, MSCAI, FACC, FAHAChief of Medicine

VA Long Beach Health Care SystemLong Beach, CA

Professor of MedicineUniversity of California, Irvine

Orange, CA

Eric Lindley, MD, FACCInterventional Cardiology

McKay-Dee HospitalOgden, UT

Ehtisham Mahmud, MD, FACC, FSCAIDivision Chief, Cardiovascular Medicine

Executive Director, Sulpizio Cardiovascular CenterUC San DiegoSan Diego, CA

Rajan Patel, MD, FACC, FAHA, FSCAISenior Lecturer, Interventional Cardiology

Ochsner Clinical SchoolUniversity of QueenslandOchsner Health System

New Orleans, LA

Ashish Pershad, MD, FACC, FSCAIDirector of Cardiac Catheterization Laboratory

Banner University Medical CenterPhoenix, AZ

Duane S. Pinto, MD, MPH, FACC, FSCAIAssociate Professor of Medicine

Harvard Medical SchoolChief, Interventional Cardiology

Director, Cardiac Intensive Care UnitBeth Israel Deaconess Medical Center

Boston, MA

Danny Ramzy, MD, PhD, FACCDirector, Robotic and Minimally Invasive Cardiac Surgery

Cedars-Sinai Medical CenterLos Angeles, CA

David Rizik, MD, FACC, MSCAIChief Scientific Officer

Director of Structural and Coronary InterventionsHonorHealth Heart Group

Scottsdale, AZ

Robert Safian, MD, FACC, FSCAIDirector, Center for Innovation and Research in Cardiovascular Diseases

Beaumont HealthRoyal Oak, MI

Jacqueline Saw, MD, FRCPC, FACC, FAHA, FSCAIClinical Professor

Vancouver General HospitalVancouver, Canada

Ajay Srivastava, MD, FACCDirector, Acute Mechanical Circulatory Support Program

Scripps ClinicLa Jolla, CA

Raj Sugumaran, MD, FACC, FSCAICardiac Solutions

Banner HealthPhoenix, AZ

Douglas Triffon, MD, FACC, FNLADirector of the Lipid Disorders Clinic

Scripps ClinicLa Jolla, CA

Robert Wilson, MDProfessor

University of MinnesotaCSIO

ACIST Medical SystemsMinneapolis, MN

George W. Vetrovec, MD, MACC, MSCAIProfessor Emeritus

Virginia Commonwealth UniversityRichmond, Virginia

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for CommercialSupport, all course director(s), presenters, moderators, planners, and peer reviewers involved in the development ofCME content are required to disclose to the accredited provider any relevant financial relationships of themselvesand their spouse/partner via a Disclosure of Relevant Financial Relationships form.

The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within thepast 12 months that create a conflict of interest. Conflicts of interest must be resolved for the individual to continueparticipation. All participants declare the following:

They will comply with the ACCME Standards for Commercial Support of Continuing Medical Educationto ensure that this CME activity is free of commercial bias or appearance thereof.

They will base all clinical recommendations on evidence that is accepted within the profession of medicineas adequate justification in the case of patients.

They will ensure that all scientific research referred to in support of a patient care recommendation willconform to generally accepted standards of experimental design, data collection, and analysis.

They will not discuss any unlabeled uses of products.

Failure to return the Disclosure of Relevant Financial Relationships form prior to the beginning of the CME activityresults in disqualification from participation in any development or presentation.

DISCLOSURES

Course Director:

Paul S. Teirstein, MD, FACC, FSCAISpeaker fees; Consultant: Abbott, Abiomed, Inc., ACIST Medical, Inc., Boston Scientific, Medtronic

Course Co-Directors:

Matthew J. Price, MD, FACC, FSCAINothing to disclose

Richard A. Schatz, MD, FACCNothing to disclose

Curtiss T. Stinis, MD, FACC, FSCAIConsultant: Abbott Vascular, Cook Medical, Edwards Lifesciences, Medtronic

Invited Faculty:

Ziad Ali, MD, DPhil

Grant, Advisory Board, Consultant, Speaker: St. Jude Medical, Boston ScientificConsultant, Speaker: ACIST Medical

Jorge A. Gonzalez, MD, FACC, FSCMRHonoraria: Boston Scientific, HeartFlow

J. Aaron Grantham, MD, FACC, FSCAIGrant, Consultant: Abbott Vascular, Boston Scientific, Asahi Intecc,

Cindy L. Grines, MD, FACC, FSCAIAdvisory Board: Abbott Vascular, VolcanoHonoraria: Abiomed, Inc.

James Hermiller, MD, FACC, FSCAIConsultant: Edwards Lifesciences, Medtronic, Abbott Vascular, Boston Scientific

Dean Kereiakes, MD, FACCConsulting Fees: Boston Scientific, Abbott Vascular, SINO Medical Sciences Technologies, Svelte Medical Systems,Inc., Micell Technologies, Inc., Caliber TherapeuticsMajor Stock Shareholder: Ablative Solutions, Inc.

Morton Kern, MD, MSCAI, FACC, FAHASpeaker: Abbott/St. Jude, ACIST Medical, HeartFlow, Philips Volcano

Ehtisham Mahmud, MD, FACC, FSCAIResearch: CorindusSpeakers Bureau, Research: Abbott VascularSpeakers Bureau: MedtronicResearch: CSI

David Rizik, MD, FACC, FSCAIMedical Advisory Board: Abbott Vascular, BIOTRONIK, Cordis, A Cardinal Health CompanyExecutive Physician Council; Grant/Research Support; Consulting/Proctor: License Fees/Royalties:Boston Scientific

Jacqueline Saw, MD, FRCPC, FACC, FAHA, FSCAIResearch: Canadian Institutes of Health Research, University of British Columbia Division of Cardiology, Heart andStroke Foundation, AstraZeneca, Abbott Vascular and ServierConsult/Advisory Board: Abbott Vascular, AstraZeneca, BayerSpeaker Honoraria: AstraZeneca, Bayer, and Sunovion

Ajay Srivastava, MD, FACCSpeaker: Abbott, Abiomed, Inc.

Douglas Triffon, MD, FACC, FNLASpeaker’s Bureau: Sanofi, Amgen, Janssen, Amarin

Planner Disclosures

Rebecca LawNothing to disclose

Laurel SteigerwaldNothing to disclose

The following faculty speakers are only participating during portions of the activity that are not accreditedand will take place in a room separate from the main scientific sessions.

Daniel Burkhoff, MD, PhD, Amir Kaki, MD, FACC, FSCAI, Eric Lindley, MD, FACC,Rajan Patel, MD, FACC, FAHA, FSCAI, Ashish Pershad, FACC, FSCAI,Duane S. Pinto, MD, MPH, FACC, FSCAI, Danny Ramzy, MD, PhD, Raj Sugumaran, MD, FACC, FSCAI